Video Experimental Relacionado
Updated: Jul 27, 2026

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Cetoacidosis diabética en prisioneros sin acceso a la insulina
A S Keller1, R N Link, N A Bickell
1Department of Medicine, University School of Medicine, New York, NY.
JAMA
|February 3, 1993
Resumen
La cetoacidosis diabética en prisioneros varones a menudo es causada por la falta de insulina después de la detención. Mejorar el acceso a la atención médica para las personas encarceladas con diabetes es crucial.
Área de la Ciencia:
- Investigación médica Investigación médica.
- Salud Pública La salud pública.
- Endocrinología Endocrinología.
Sus antecedentes:
- La cetoacidosis diabética (CDA) es una complicación grave de la diabetes.
- Las poblaciones encarceladas pueden enfrentar desafíos únicos en el manejo de enfermedades crónicas como la diabetes.
Objetivo del estudio:
- Para investigar las causas y la gravedad clínica de la DKA en prisioneros varones en la ciudad de Nueva York.
- Para identificar los factores que contribuyen a las admisiones DKA entre este grupo demográfico.
Principales métodos:
- Se realizó una revisión retrospectiva del gráfico.
- Se analizaron datos de 54 hospitalizaciones por DKA en prisioneros varones adultos entre 1989 y 1991.
Principales resultados:
- El 70% de las admisiones de DKA se debió a la falta de insulina después de la detención, con un retraso promedio de 2.5 días para la hospitalización.
- Los pacientes tenían antecedentes de diabetes insulino-dependiente y eran compatibles antes de la detención.
- La glucosa sérica promedio fue de 27,4 mmol/L, el bicarbonato sérico promedio fue de 14,4 mmol/L, con una estancia hospitalaria promedio de 3,4 días.
Conclusiones:
- El acceso inadecuado a los medicamentos esenciales, específicamente la insulina, conduce a graves consecuencias para la salud de los reclusos recientemente arrestados con diabetes insulino-dependiente.
- Existe una necesidad crítica de mejorar el acceso a la atención médica para las personas recién encarceladas con diabetes para prevenir la DKA y mejorar los resultados.
Videos de Conceptos Relacionados
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...

